Tuesday, Jan 14, 2025 · SEC filings

What the smart money revealed on Jan 14

Real insider buys16insiders · $2.6M
Real insider sales44insiders · $10.8M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

415 insider filings came in. We hid 60 planned (10b5-1) sellers and 273 people whose filings were routine, like grants and tax withholding.

trending_up

Norris Industries (NRIS) Chairman Patrick Norris bought $1.39M

17.36M shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 10
$1.39M
trending_up

Avadel Pharmaceuticals (AVDL) Director Eric Ende bought $235K

30,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 13
$235K
trending_up

Generation Bio (GBIO) Director Anthony Quinn bought $203K

210,791 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 10–13
$203K
trending_up

Lamb Weston (LW) Director Robert Niblock bought $183K

3,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 13
$183K
trending_down

Jabil (JBL) Director Steven Raymund sold $3.03M

Not marked as a planned 10b5-1 sale. Sold 14% of the shares they held directly. Still holds 119,108 shares.

Real sale Form 4 Traded Jan 10
$3.03M
trending_down

Argan (AGX) Director Peter Getsinger sold $1.34M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 11,792 shares directly.

Real sale Form 4 Traded Jan 10–14
$1.34M
trending_down

FedEx (FDX) Director Susan Schwab sold $1.1M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 8,904 shares directly.

Real sale Form 4 Traded Jan 14
$1.1M
Show 12 more real buys
Show 41 more real sales
DOCU DocuSign · Director Enrique Salem · Traded Jan 10
$916K
ILLR Triller Group · Director Robert Diamond Jr. · Traded Jan 10–14
$759K
G Genpact · Senior Vice President and CHRO Piyush Mehta · Traded Jan 10
$514K
OFIX Orthofix Medical · President and CEO Massimo Calafiore · Traded Jan 10–13
$327K
FICO Fair Isaac · Executive Vice President and CFO Steven Weber · Traded Jan 9
$273K
TWST Twist Bioscience · CFO Adam Laponis · Traded Jan 10
$255K
AMBA Ambarella · COO Chan Lee · Traded Jan 10–14
$223K
FTRE Fortrea · CEO Thomas Pike · Traded Jan 13
$203K
CBL CBL & Associates Properties · Exec VP-Accounting Andrew Cobb · Traded Jan 10
$196K
APLS Apellis Pharmaceuticals · CEO Cedric Francois · Traded Jan 13
$179K
JOBY Joby Aviation · Chief Product Officer Eric Allison · Traded Jan 13
$170K
TRAK ReposiTrak · CEO Randall Fields · Traded Jan 13
$154K
APLS Apellis Pharmaceuticals · General Counsel David Watson · Traded Jan 13
$142K
PI Impinj · CEO Chris Diorio · Traded Jan 13
$119K
APLS Apellis Pharmaceuticals · Chief Commercial Officer Adam Townsend · Traded Jan 13
$77.1K
APLS Apellis Pharmaceuticals · Chief Technical Officer Nur Nicholson · Traded Jan 13
$75.5K
EDR Endeavor Group · Global Controller and CAO William Fullerton · Traded Jan 14
$68K
APLS Apellis Pharmaceuticals · Chief Scientific Officer Pascal Deschatelets · Traded Jan 13
$65.7K
APLS Apellis Pharmaceuticals · CFO Timothy Sullivan · Traded Jan 13
$62.3K
PI Impinj · Chief Revenue Officer Jeffrey Dossett · Traded Jan 13
$53.3K
JOBY Joby Aviation · Officer Kate DeHoff · Traded Jan 13
$50.3K
PI Impinj · COO Hussein Mecklai · Traded Jan 13
$47.7K
APLS Apellis Pharmaceuticals · Chief Business and Strat Officer Mark DeLong · Traded Jan 13
$45.9K
APLS Apellis Pharmaceuticals · Chief People Officer Karen Lewis · Traded Jan 13
$45.9K
SDIG Stronghold Digital Mining · CEO Gregory Beard · Traded Jan 10
$45.3K
VSTM Verastem · President and CEO Dan Paterson · Traded Jan 13
$44.9K
SNCY Sun Country Airlines · President and CFO David Davis · Traded Jan 10
$44K
PI Impinj · CFO Cary Baker · Traded Jan 13
$40.9K
CHCI Comstock Holding Companies · Chairman and CEO Christopher Clemente · Traded Jan 10
$36.3K
APLS Apellis Pharmaceuticals · VP/Chief Accounting Officer James Chopas · Traded Jan 13
$22.5K
MXCT Maxcyte · General Counsel David Sandoval · Traded Jan 13
$20.3K
SNCY Sun Country Airlines · Chief Acct. Off. and VP John Gyurci · Traded Jan 10
$16K
NRGV Energy Vault · Chief Engineering Officer Akshay Ladwa · Traded Jan 10
$9.33K
OFIX Orthofix Medical · CAO Geoffrey Gillespie · Traded Jan 10–13
$8.06K
APLS Apellis Pharmaceuticals · Chief Development Officer Jeffrey Eisele · Traded Jan 13
$7.58K
ACCD Accolade · CEO Rajeev Singh · Traded Jan 13
$3.72K
CBUS Cibus · Director Gerhard Prante · Traded Jan 13
$2.69K
ACCD Accolade · CFO Stephen Barnes · Traded Jan 13
$1.95K
ACCD Accolade · President Robert Cavanaugh · Traded Jan 13
$1.76K
FTHM Fathom · CFO Joanne Zach · Traded Jan 2
$1.3K
FTHM Fathom · Chief Broker Officer Samantha Giuggio · Traded Jan 2–10
$1.26K

13F season

Holdings as of Dec 31, 2024 are due Feb 14

81 funds have filed so far. 58 filed for the quarter before.

Biggest real insider buys, Jan 8–14

Open-market buys by officers and directors, filed in the 7 days up to Jan 14.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist